Clinical Trials Browser

Phase 2 × Breast Neoplasms, Male × Capecitabine × Clear all

NCT00562718 2020-08-21

Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery

Phase 2 Completed

50 enrolled 10 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00274768 2020-01-27

Capecitabine in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

26 enrolled 12 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00093808 2017-03-06

Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

47 enrolled 8 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00088998 2016-12-07

Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00265733 2016-12-06

Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00450515 2016-12-06

Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms, Breast Neoplasms, Male

NCT00068588 2014-10-31

GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

24 enrolled 4 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00967031 2013-01-18

Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain Metastases

Phase 2 Completed

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

NCT00227656 2012-12-11

Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer

Phase 2 Terminated

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male